RVS — Revasum Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro Cap

Annual income statement for Revasum, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

	2018 December 31st	2020 January 5th	2021 January 3rd	2022 January 2nd	2023 January 1st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	27.3	20.5	15.4	13.7	14.7
Cost of Revenue
Gross Profit	10.2	2.29	4.89	4.84	4.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	28.3	35.4	24.3	19	22.6
Operating Profit	-1.02	-14.9	-8.93	-5.24	-7.89
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-4.36	-14.9	-9.16	-1.97	-8.93
Provision for Income Taxes
Net Income After Taxes	-4.36	-14.9	-9.16	-1.97	-8.93
Net Income Before Extraordinary Items
Net Income	-4.36	-14.9	-9.16	-1.97	-8.93
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4.36	-14.9	-9.16	-1.97	-8.93
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.037	-0.176	-0.078	-0.019	-0.083